{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T23:39:23Z","timestamp":1790638763217,"version":"4.1.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,30]],"date-time":"2022-11-30T00:00:00Z","timestamp":1669766400000},"content-version":"vor","delay-in-days":2190,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005629","name":"Viropharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005629","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004321","name":"Shire","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004321","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1111\/ajt.13871","type":"journal-article","created":{"date-parts":[[2016,5,17]],"date-time":"2016-05-17T00:52:55Z","timestamp":1463446375000},"page":"3468-3478","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":162,"title":["Plasma-Derived C1 Esterase Inhibitor for Acute Antibody-Mediated Rejection Following Kidney Transplantation: Results of a Randomized Double-Blind Placebo-Controlled Pilot Study"],"prefix":"10.1016","volume":"16","author":[{"given":"R.A.","family":"Montgomery","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.J.","family":"Orandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Racusen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.M.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.M.","family":"Garonzik-Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.S.","family":"Woodle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Sommerer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Fitts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Rockich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.E.","family":"Uknis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/ajt.13871_bib1","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.1600-6143.2009.03001.x","article-title":"Renal transplantation across HLA and ABO antibody barriers: Integrating paired donation into desensitization protocols","volume":"10","author":"Montgomery","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.13871_bib2","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1046\/j.1523-1755.1999.00299.x","article-title":"The Banff 97 working classification of renal allograft pathology","volume":"55","author":"Racusen","year":"1999","journal-title":"Kidney Int"},{"key":"10.1111\/ajt.13871_bib3","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1111\/j.1600-6143.2007.01995.x","article-title":"Transplant glomerulopathy: Ultrastructural abnormalities occur early in longitudinal analysis of protocol biopsies","volume":"7","author":"Wavamunno","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.13871_bib4","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1097\/00007890-200009270-00006","article-title":"Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients","volume":"70","author":"Montgomery","year":"2000","journal-title":"Transplantation"},{"key":"10.1111\/ajt.13871_bib5","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1097\/TP.0000000000000298","article-title":"Eculizumab and splenectomy as salvage therapy for severe antibody-mediated rejection after HLA-incompatible kidney transplantation","volume":"98","author":"Orandi","year":"2014","journal-title":"Transplantation"},{"key":"10.1111\/ajt.13871_bib6","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1517\/13543784.15.9.1077","article-title":"The therapeutic potential of a kallikrein inhibitor for treating hereditary angioedema","volume":"15","author":"Levy","year":"2006","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1111\/ajt.13871_bib7","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1681\/ASN.2008121268","article-title":"Molecular phenotypes of acute rejection predict kidney graft prognosis","volume":"21","author":"Viklicky","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/ajt.13871_bib8","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1681\/ASN.V133779","article-title":"Acute humoral rejection in kidney transplantation: II. Morphology, immunopathology, and pathologic classification","volume":"13","author":"Mauiyyedi","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/ajt.13871_bib9","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/j.1600-6143.2009.02987.x","article-title":"Banff \u201809 meeting report: Antibody mediated graft deterioration and implementation of Banff working groups","volume":"10","author":"Sis","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.13871_bib10","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1097\/01.TP.0000442513.27641.7e","article-title":"Histologic phenotype on 1-year posttransplantation biopsy and allograft survival in HLA-incompatible kidney transplants","volume":"97","author":"Sharif","year":"2014","journal-title":"Transplantation"},{"key":"10.1111\/ajt.13871_bib11","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1111\/j.1600-6143.2009.02836.x","article-title":"The impact of c4d pattern and donor-specific antibody on graft survival in recipients requiring indication renal allograft biopsy","volume":"9","author":"Haririan","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.13871_bib12","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1111\/ajt.13168","article-title":"Positive crossmatch kidney transplant recipients treated with eculizumab: Outcomes beyond 1 year","volume":"15","author":"Cornell","year":"2015","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.13871_bib13","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1097\/00007890-200110150-00022","article-title":"The allogeneic T and B cell response is strongly dependent on complement components C3 and C4","volume":"72","author":"Marsh","year":"2001","journal-title":"Transplantation"},{"key":"10.1111\/ajt.13871_bib14","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/ki.2010.75","article-title":"Recombinant human C1-inhibitor prevents acute antibody-mediated rejection in alloimmunized baboons","volume":"78","author":"Tillou","year":"2010","journal-title":"Kidney Int"},{"key":"10.1111\/ajt.13871_bib15","unstructured":"Cinryze [prescribing information]. Lexington, MA: Shire ViroPharma Incorporated; 2014."},{"key":"10.1111\/ajt.13871_bib16","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1111\/j.1600-6143.2007.01895.x","article-title":"Transplant glomerulopathy: Subclinical incidence and association with alloantibody","volume":"7","author":"Gloor","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.13871_bib17","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1111\/j.1600-6143.2011.03647.x","article-title":"Early ultrastructural changes in renal allografts: Correlation with antibody-mediated rejection and transplant glomerulopathy","volume":"11","author":"Haas","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.13871_bib18","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/ki.1985.83","article-title":"Transplant glomerulopathy: Evolution of morphologically distinct changes","volume":"27","author":"Maryniak","year":"1985","journal-title":"Kidney Int"},{"key":"10.1111\/ajt.13871_bib19","doi-asserted-by":"crossref","first-page":"549315","DOI":"10.1155\/2014\/549315","article-title":"Transplant glomerulopathy: The interaction of HLA antibodies and endothelium","volume":"2014","author":"Hanf","year":"2014","journal-title":"J Immunol Res"},{"key":"10.1111\/ajt.13871_bib20","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.humimm.2011.02.002","article-title":"Donor human leukocyte antigen specific antibodies predict development and define prognosis in transplant glomerulopathy","volume":"72","author":"Eng","year":"2011","journal-title":"Hum Immunol"},{"key":"10.1111\/ajt.13871_bib21","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/TP.0000000000000592","article-title":"A phase I\/II placebo-controlled trial of C1-inhibitor for prevention of antibody-mediated rejection in HLA sensitized patients","volume":"99","author":"Vo","year":"2015","journal-title":"Transplantation"},{"key":"10.1111\/ajt.13871_bib22","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1111\/ajt.13663","article-title":"C1-Inhibitor in acute antibody-mediated rejection non-responsive to conventional therapy in kidney transplant recipients: A pilot study","volume":"16","author":"Viglietti","year":"2016","journal-title":"Am J Transplant"}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fajt.13871","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fajt.13871","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S160061352200689X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S160061352200689X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/ajt.13871\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:15:42Z","timestamp":1761628542000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S160061352200689X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":22,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S160061352200689X"],"URL":"https:\/\/doi.org\/10.1111\/ajt.13871","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasma-Derived C1 Esterase Inhibitor for Acute Antibody-Mediated Rejection Following Kidney Transplantation: Results of a Randomized Double-Blind Placebo-Controlled Pilot Study","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/ajt.13871","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}